Liraglutide (Saxenda®) PGD Training 2020/21

​

Expert Clinic (EC) and Voyager Medical (VM) have jointly organised the Saxenda webinar and PGD-accredited services for pharmacists and allied healthcare professionals. 

​

​

The EC and VM training programme has two parts:

​

Part (I) – Webinar

Part (II) – PGD online assessment with support materials

​

What is Liraglutide (Saxenda®)

​

The Liraglutide (Saxenda®) 3mg injection is an injectable prescription medicine that may help some overweight (BMI >27) and obese (BMI >30) adults who suffer with weight-related illnesses to lose weight and keep the weight off. Saxenda® should only be used in conjunction with a reduced-calorie meal plan and increased physical activity.

​

​

How Liraglutide (Saxenda®) Works

​

• Liraglutide (Saxenda®) addresses one of the body's natural responses to weight loss.

• The human body produces an appetite hormone known as glucagon-like-peptide (GLP-1) and it is this hormone that helps to regulate hunger.

• Liraglutide (Saxenda®) works like GLP-1 to regulate the appetite, resulting in the consumption of fewer calories and weight loss.

• Liraglutide (Saxenda®) is not a stimulant.

• Overview of Training Content

• Obesity as a Disease.

• Current Management of Obesity in the United Kingdom.

• Glucagon-like Peptide-1 (GLP-1) and Liraglutide (Saxenda) 

• SCALE Clinical Programme on efficacy and safety profile of Liraglutide (Saxenda)

• The XENSOR Study – Real-world study comparing effectiveness and tolerability of Orlistat and Liraglutide

• Safety Profile and Requirements for Liraglutide

• Practical Considerations on Liraglutide (Saxenda) – demonstration using Saxenda placebo pen by trainer.

• How to set up a weight management clinic in a pharmacy setting using Voyager Medical’s accredited PGDs on weight management.